News since the closing bell:
said it earned $1.10 a share on an operating basis in its second quarter, compared with the
consensus estimate of $1.08 and the year-ago's 85 cents a share.
said it earned 16 cents a share in its fourth quarter, lower than the consensus analysts' estimate of 18 cents a share and below the year-ago's 35 cents.
(BSN:NYSE) said it earned 19 cents a share in its fourth quarter, better than the consensus estimate of 17 cents a share and the year-earlier's loss of 72 cents a share.
SBH ADS) Carvedilol was backed by a
Food and Drug Administration
panel to treat congestive heart failure.
By Erle Norton